Cannabinoid: Difference between revisions
>Oskykins |
>Oskykins |
||
Line 69: | Line 69: | ||
===Toxicity and harm potential=== | ===Toxicity and harm potential=== | ||
Compared to cannabis and its active cannabinoid THC, the adverse effects are often much more severe and can include hypertension, tachycardia, myocardial infarction,[36] agitation, vomiting, hallucinations, psychoses, seizures, convulsions[37] and panic attacks.[38][39][40][41][42] Among individuals who need emergency treatment after using synthetic cannabis, the most common symptoms are accelerated heartbeat, high blood pressure, nausea, blurred vision, hallucination and agitation.[43] Other symptoms included epileptic seizures, acute psychosis, and heart attacks.[43] | |||
The use of synthetic cannabinoids can be associated with psychosis. In contrast to most other recreational drugs, the dramatic psychotic state induced by use of synthetic cannabinoids has been reported, in multiple cases, to persist for several weeks, and in one case for seven months, after complete cessation of drug use.[50] Individuals with risk factors for psychotic disorders are often counseled against using synthetic cannabinoids.[51] | |||
These more severe adverse effects in contrast to use of marijuana are believed to stem from the fact that many of the synthetic cannabinoids are full agonists to the cannabinoid receptors, CB1R and CB2R, compared to THC which is only a partial agonist and thus not able to saturate and activate all of the receptor population no matter of dose and resulting concentration.[46] | |||
Synthetic cannabinoids are known to be active at microgram doses. Because of this, it is extremely important to start with very low doses until a reasonable tolerance is built to the materials. | Synthetic cannabinoids are known to be active at microgram doses. Because of this, it is extremely important to start with very low doses until a reasonable tolerance is built to the materials. | ||